Trilateral Project 24.1-Biotechnology 108

Again, there are no general rules concerning the enablement of monoclonal antibodies. The disclosure of the specification and the properties of the antibody being claimed must be evaluated to determine whether or not one could reproducibly make the claimed antibody without an undue amount of experimentation.

If, based on the description of the procedures and the working example, one could make antibodies within the scope of the claims, no deposit would be required for enablement.